English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In a recent study by Hoffmann M et al. [1], interferon (INF)-gamma-based QuantiFERON®-TB Gold In-Tube test (QFT-G) was found to be a valid alternative to theTST in haemodialysis (HD) patients. They also noted that INF-gamma secretion in HD patients was significantly lower than in healthy controls. This was independent of the nutritional status (serum albumin, nPCR) and of the amount of dialysis (spKt/v).

The interferon-gamma-based QuantiFERON®-TB Gold in-tube test and the type of hemodialysis process